Majuven

Majuven is an early and growth stage venture capital firm based in Singapore, focusing on disruptive trends in healthcare, financial services, and digital consumerism. The firm typically invests in companies at Seed to Series B stages, targeting high-growth Asian tech businesses that have begun monetization strategies. Majuven's investment size ranges from early-stage seed rounds to larger Series C investments.

Eureka Therapeutics, a biotech company that has raised $21 million, is a notable portfolio company. Majuven offers portfolio companies access to its extensive network, which is crucial for their regionalization plans. Founded by experienced business leaders in 2012, the firm's investment philosophy centers on backing visionaries creating new categories and business models in technology-intensive sectors.